NCT02986178 2025-07-11
Lerapolturev in Recurrent Malignant Glioma
Istari Oncology, Inc.
Phase 2 Completed
Istari Oncology, Inc.
Eli Lilly and Company
Sahlgrenska University Hospital
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
Indiana University
European Organisation for Research and Treatment of Cancer - EORTC